Paradigm Therapeutics - Ownership and Business Overview

Life ScienceCompany

Paradigm Therapeutics Ownership

Who owns Paradigm Therapeutics?

Paradigm Therapeutics is owned by Takeda Pharmaceutical. It was acquired on March 12, 2007.

Paradigm Therapeutics Business Overview

Where is Paradigm Therapeutics headquartered?

Paradigm Therapeutics is headquartered in Cambridge, United Kingdom.

What sector is Paradigm Therapeutics in?

Paradigm Therapeutics is a life science company.

When was Paradigm Therapeutics founded?

Paradigm Therapeutics was founded in 1998.

Life Science M&A Summary in 2007

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 130 acquisitions of life science companies in 2007, including 28 acquisitions by private equity firms, and 102 by strategics.

Paradigm Therapeutics, Ltd.

418 Science Park Milton Road,
Cambridge, CB4 0PZ
United Kingdom,
44 12 2347 7910

Paradigm Therapeutics, Ltd. has established world-class target identification and validation capabilities based on genetic engineering and in vivo pharmacology. Paradigm has already developed a promising pipeline of novel drug discovery targets and compounds in key areas of unmet medical need including pain, CNS disorders, prostate and breast cancer, diabetes, hyperlipidemia, and obesity.


 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Paradigm Therapeutics

Life Science Companies , United Kingdom Companies